| FIELD OF APPLICATION | DETAILS |
|---|---|
| Generic Name | Brimonidine tartrate and timolol maleate |
| Active Ingredient | Brimonidine tartrate, Timolol maleate |
| US Brand Names | Combigan |
| Drug Category | OphthalmologyOphthalmic Agents |
| Drug Class | Alpha-2 Adrenergic Agonist, Beta-Adrenergic Blocker, Anti-Glaucoma Combination |
| Route of Administration | Ophthalmic (Topical Eye Drops) |
| FDA Approval Status | FDA Approved (October 2007) Approved |
Brimonidine Tartrate; Timolol Maleate Overview
Brimonidine tartrate and timolol maleate combination is a fixed-dose ophthalmic solution containing an alpha-2 adrenergic receptor agonist and a non-selective beta-adrenergic receptor blocker. It is an FDA-approved prescription medication designed to lower elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension. Ophthalmologists and eye care specialists prescribe this dual-action agent when single-agent therapy provides insufficient eye pressure reduction.
What Is Brimonidine Tartrate; Timolol Maleate & How Does It Work?
This fixed-dose combination eye drop combines two distinct pharmacological mechanisms to lower intraocular pressure and protect optic nerve structure. In open-angle glaucoma and ocular hypertension, impaired fluid drainage causes aqueous humor to accumulate inside the eye. This increased fluid pressure damages sensitive optic nerve fibers over time, leading to irreversible peripheral vision loss and potential blindness.
Brimonidine tartrate works as a selective alpha-2 adrenergic agonist that reduces aqueous humor production by the ciliary body while simultaneously increasing fluid outflow through the secondary uveoscleral drainage pathway. Timolol maleate is a non-selective beta-adrenergic receptor blocking agent that reduces aqueous humor formation by inhibiting beta receptors in the ciliary epithelium. By targeting both fluid production and drainage mechanisms at the same time, this combination drop achieves significantly greater reductions in intraocular pressure than either medication used individually.
Is Brimonidine Tartrate; Timolol Maleate FDA Approved?
Yes, the combination of Brimonidine tartrate and Timolol maleate ophthalmic solution is officially approved by the United States Food and Drug Administration. It was initially approved on October 30, 2007, following clinical trials demonstrating its safety and superior pressure-lowering efficacy compared to individual monotherapies.
What Is Brimonidine Tartrate; Timolol Maleate Used For?
- It is FDA-approved for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension who require multi-drug therapy.
- It is indicated for individuals who require additional eye pressure control when single-agent drops do not achieve target levels.
- It is utilized within the Ophthalmology department at Liv Hospital to preserve visual fields and manage progressive glaucoma cases effectively.
Before Taking Brimonidine Tartrate; Timolol Maleate: Contraindications & Precautions
Eye care professionals at Liv Hospital conduct comprehensive ocular and systemic evaluations before prescribing this combination drop. Because timolol is a beta blocker absorbed systemically through the nasal mucosa, a detailed cardiovascular and pulmonary screening is mandatory.
Who Should Not Take Brimonidine Tartrate; Timolol Maleate?
- Patients with bronchial asthma, a history of bronchial asthma, or severe chronic obstructive pulmonary disease (COPD).
- Individuals with sinus bradycardia, second-degree or third-degree atrioventricular (AV) block, overt cardiac failure, or cardiogenic shock.
- Neonates and pediatric patients under 2 years of age, due to severe risks of central nervous system depression and respiratory collapse.
- Anyone with a known hypersensitivity or severe allergic reaction to brimonidine tartrate, timolol maleate, or any component of the eye drop solution.
Brimonidine Tartrate; Timolol Maleate, Pregnancy & Fertility
- Pregnancy: There are no adequate and well-controlled studies of this combination in pregnant women. Systemic absorption of timolol and brimonidine can occur, so pregnant individuals should use this medication only if the potential benefit justifies potential fetal risks.
- Breastfeeding: Both timolol and brimonidine have been detected in human breast milk. Because of the potential for serious adverse reactions in nursing infants, a decision should be made whether to discontinue nursing or discontinue the drug, taking into account its importance to the mother.
Tell Your Doctor Before Taking Brimonidine Tartrate; Timolol Maleate
- Inform your eye doctor if you have a history of heart disease, congestive heart failure, low blood pressure, or circulation disorders like Raynaud’s phenomenon.
- Disclose any diagnosis of diabetes, hypoglycemia, or thyroid disorders, as beta blockers can mask warning signs of low blood sugar or hyperthyroidism.
- Provide a complete list of all active prescription eye drops, oral blood pressure medications, beta blockers, heart drugs, and antidepressants (such as MAO inhibitors or SSRIs).
Brimonidine Tartrate; Timolol Maleate Dosage & Administration
This combination solution must be administered twice daily to maintain consistent intraocular pressure control throughout a 24-hour cycle.
Standard Brimonidine Tartrate; Timolol Maleate Dosing
- Open-Angle Glaucoma & Ocular Hypertension: Instill 1 drop in the affected eye(s) twice daily (approximately every 12 hours).
How Brimonidine Tartrate; Timolol Maleate Is Administered
- Wash your hands thoroughly with soap and water before handling the bottle.
- Tilt your head back, pull down the lower eyelid to form a small pocket, and instill 1 drop into the eye.
- Close your eye gently for 1 to 2 minutes while placing light pressure on the inner corner of the eye (nasolacrimal occlusion) to minimize systemic absorption into the bloodstream.
- If using other topical eye drops, wait at least 5 to 10 minutes between instilling different medications.
- Remove soft contact lenses before instilling the drops and wait at least 15 minutes before reinserting them.
Brimonidine Tartrate; Timolol Maleate Clinical Efficacy & Research
The clinical efficacy of this combination eye drop is established by two multi-center, randomized, double-masked Phase 3 clinical trials comparing it with individual brimonidine and timolol monotherapies. In these studies, Brimonidine tartrate and Timolol maleate combination achieved mean intraocular pressure reductions of 1 to 3 mmHg greater than timolol alone and 1 to 6 mmHg greater than brimonidine alone across 12 months of follow-up. Efficacy data confirmed sustained pressure-lowering control throughout daytime measurements, demonstrating that fixed combination therapy simplifies treatment regimens while delivering superior intraocular pressure control.
Brimonidine Tartrate; Timolol Maleate Side Effects & Safety Profile
This combination eye drop is well tolerated by most adults, but localized ocular reactions and systemic side effects related to beta-blocker or alpha-agonist exposure can occur.
Brimonidine Tartrate; Timolol Maleate Black Box Warning
This medication does not have an FDA Black Box Warning.
Brimonidine Tartrate; Timolol Maleate Common Side Effects
- Conjunctival hyperemia (eye redness) or mild allergic conjunctivitis.
- Transient eye burning, stinging, or mild ocular irritation upon instillation.
- Visual disturbances or transient blurred vision.
- Oral dryness, mild fatigue, or drowsiness.
- Mild headache or eyelid itching (pruritus).
Serious Brimonidine Tartrate; Timolol Maleate Adverse Events
- Severe pulmonary reactions, including bronchospasm or respiratory distress in patients with asthma or COPD.
- Severe cardiovascular events, including marked bradycardia, hypotension, cardiac heart block, or worsening heart failure.
- Severe ocular hypersensitivity, marked corneal epithelial toxicity, or allergic blepharoconjunctivitis.
- Masked symptoms of acute hypoglycemia in diabetic patients or masked hyperthyroidism symptoms.
Managing Brimonidine Tartrate; Timolol Maleate Side Effects
Mild stinging immediately after drop application usually subsides within a few seconds. Performing nasolacrimal occlusion (pressing the inner corner of your eye for 2 minutes after instilling drops) significantly reduces systemic absorption and reduces systemic side effects like drowsiness, dry mouth, or slow heart rate. If you experience severe shortness of breath, sudden wheezing, severe dizziness, slow pulse, or severe eye pain, discontinue use and seek immediate emergency care.
Brimonidine Tartrate; Timolol Maleate Interactions & What to Avoid
Because systemically absorbed timolol and brimonidine can interact with systemic drugs, careful review of your medication list is essential.
Brimonidine Tartrate; Timolol Maleate Interactions
- Oral Beta-Adrenergic Blockers: Concomitant use with oral beta blockers may produce additive systemic beta-blockade effects, leading to severe bradycardia or low blood pressure.
- Calcium Channel Blockers & Digitalis: Combining this drop with drugs like verapamil, diltiazem, or digoxin increases the risk of AV conduction disturbances, slow heart rate, and heart failure.
- Central Nervous System Depressants: Concurrent use with alcohol, sedatives, or opiates can increase central nervous system depression, fatigue, or somnolence.
- CYP2D6 Inhibitors: Potent CYP2D6 inhibitors (such as quinidine, fluoxetine, or paroxetine) can inhibit timolol metabolism, enhancing systemic beta-blockade effects.
Brimonidine Tartrate; Timolol Maleate Food & Alcohol
- Avoid consuming alcohol while using this eye drop if you experience drowsiness, as alcohol can amplify central nervous system sedation.
Brimonidine Tartrate; Timolol Maleate Missed Dose, Overdose & Storage
Following proper handling, storage, and dosing routines maintains solution sterility and ensures reliable pressure control.
Missed Dose of Brimonidine Tartrate; Timolol Maleate
If you miss a dose, instill 1 drop as soon as you remember. If it is almost time for your next scheduled dose, skip the missed drop and resume your regular twice-daily schedule without instilling extra drops.
Brimonidine Tartrate; Timolol Maleate Overdose & Emergency
An accidental ocular overdose of extra drops will drain naturally without systemic harm. If the bottle contents are accidentally ingested, especially by a young child, seek immediate emergency medical treatment or call a poison control center right away.
How to Store Brimonidine Tartrate; Timolol Maleate
- Store the bottle in an upright position at controlled room temperature between 15°C and 25°C (59°F and 77°F).
- Keep the container tightly closed and protect it from light and excessive heat.
- Do not touch the dropper tip to any surface to maintain solution sterility.
Brimonidine Tartrate; Timolol Maleate Patient Management & Monitoring
Regular clinical evaluations at Liv Hospital help verify target intraocular pressure and monitor both ocular surface and systemic health.
Tests Before Starting Brimonidine Tartrate; Timolol Maleate
- Comprehensive dilated eye examination and baseline intraocular pressure measurement using calibrated tonometry.
- Visual field testing and optical coherence tomography (OCT) of the optic nerve head.
- Baseline cardiovascular and pulmonary evaluation, including pulse rate, blood pressure, and respiratory history.
Monitoring During Brimonidine Tartrate; Timolol Maleate Treatment
- Regular intraocular pressure checks every 3 to 6 months to confirm treatment efficacy.
- Periodic visual field testing and optic nerve imaging to monitor glaucoma stability.
- Regular monitoring of pulse rate, blood pressure, and airway status during routine clinical follow-up.
Brimonidine Tartrate; Timolol Maleate Do’s and Don’ts
- Do perform nasolacrimal occlusion for 2 minutes after instilling drops to minimize systemic absorption.
- Do remove soft contact lenses prior to applying eye drops and wait at least 15 minutes before putting them back in.
- Don’t use this medication if you have a history of asthma or severe heart rhythm disorders.
- Don’t touch the bottle dropper tip to your eye, eyelids, or fingers.
Frequently Asked Questions
What is this combination eye drop used for?
It is a prescription eye drop used to lower high fluid pressure inside the eye in patients with open-angle glaucoma or ocular hypertension.
How do these two active ingredients work together?
Brimonidine decreases fluid production and increases fluid drainage, while timolol decreases fluid production. Together, they lower eye pressure more than either medication used alone.
How often should I use this eye drop?
The standard recommended dosage is 1 drop in the affected eye(s) twice daily, spaced about 12 hours apart.
Why is it important to press the inner corner of my eye after applying drops?
Pressing the inner corner of your eye (nasolacrimal occlusion) for 2 minutes stops the liquid from draining into your nose and bloodstream, reducing systemic side effects like slow heart rate or fatigue.
Can people with asthma use this eye drop?
No. Because timolol is a non-selective beta blocker, systemically absorbed drug can trigger severe bronchospasm and asthma attacks. It is contraindicated in patients with asthma.
Can I wear contact lenses while using this medication?
You must remove soft contact lenses before instilling the drops because the preservative can be absorbed by the lenses. Wait at least 15 minutes before reinserting your contact lenses.
What should I do if my eye becomes very red or itchy?
Mild redness can occur, but marked allergic conjunctivitis or eyelid swelling may indicate an allergic reaction to brimonidine or timolol. Contact your ophthalmologist to evaluate whether a medication change is needed.
References
- U.S. FDA – Brimonidine Tartrate and Timolol Maleate prescribing information
- U.S. FDA Drugs@FDA – Brimonidine Tartrate and Timolol Maleate approval overview
- National Institutes of Health (NIH) – Ophthalmic Beta Blockers and Combination Glaucoma Therapies Guidance.
Legal Disclaimer
The information provided is for educational and informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider at Liv Hospital or your local clinic before starting or stopping any medication.
